<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1547">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04343339</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL20_0195</org_study_id>
    <nct_id>NCT04343339</nct_id>
  </id_info>
  <brief_title>Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment</brief_title>
  <acronym>EPILOGUE</acronym>
  <official_title>Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment - EPILOGUE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current containment linked to COVID-19 will have consequences for people suffering from
      addiction and there is a risk of overdoses when the containment ends. So the investigators
      hypothesize that this health crisis is an opportunity to develop risk reduction and access to
      care for vulnerable people who lives with an addiction.

      The main objective of this study is to describe the changes in the psychoactive substances
      consumption during the containment in people suffering from addiction. The secondary
      objectives are to describe the evolution at 1 month from the end of the containment of
      problematic consumption and the level of access to care of these users
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 8, 2020</start_date>
  <completion_date type="Actual">September 30, 2020</completion_date>
  <primary_completion_date type="Actual">July 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evolution of consumption</measure>
    <time_frame>1 day</time_frame>
    <description>measurement of the difference in drugs consumption caused by containment (delta)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evolution of consumption</measure>
    <time_frame>1 month after confinmant</time_frame>
    <description>measurement of the difference in drugs consumption caused by containment (delta)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>health care access</measure>
    <time_frame>1 day</time_frame>
    <description>number of drug users referred to care (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>health care access</measure>
    <time_frame>1 month after confinmant</time_frame>
    <description>number of drug users referred to care (%)</description>
  </secondary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>Addiction, Substance</condition>
  <condition>COVID-19</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Person who lives with an addiction accepting the principle of the study
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  &gt;18 years

          -  Accept study

          -  live with an addiction

        Exclusion criteria:

        - not being able to answer the questionnaire
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hélène Donnadieu-Rigole, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 8, 2020</study_first_submitted>
  <study_first_submitted_qc>April 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2020</study_first_posted>
  <last_update_submitted>October 6, 2020</last_update_submitted>
  <last_update_submitted_qc>October 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Risk of overdose on de-confinment</keyword>
  <keyword>COVID-19 containment will change drugs practices</keyword>
  <keyword>COVID-19 containment will changes access to care</keyword>
  <keyword>Addiction is a common disease</keyword>
  <keyword>Alcohol</keyword>
  <keyword>Containment</keyword>
  <keyword>Drug use</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
    <mesh_term>Behavior, Addictive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

